Major complications and mortality after ventral hernia repair: an eleven-year Swedish nationwide cohort study.


Journal

BMC surgery
ISSN: 1471-2482
Titre abrégé: BMC Surg
Pays: England
ID NLM: 100968567

Informations de publication

Date de publication:
13 Dec 2022
Historique:
received: 12 06 2022
accepted: 01 12 2022
entrez: 13 12 2022
pubmed: 14 12 2022
medline: 16 12 2022
Statut: epublish

Résumé

Ventral hernia repair is one of the most common surgical procedures performed worldwide. Despite the large volume, consensus is lacking regarding indications for repair or choice of surgical method used for reconstruction. The aim of this study was to explore the risk for major complications and mortality in ventral hernia repair using data from a nationwide patient register. Patient data of individuals over 18 years of age who had a ventral hernia procedure between 2004 and 2014 were retrieved from the Patient Register kept by the Swedish National Board of Health and Welfare. After exclusion of patients with concomitant bowel surgery, 45 676 primary surgical admissions were included. Procedures were dichotomised into laparoscopic and open surgery, and stratified for primary and incisional hernias. A total of 45 676 admissions were analysed. The material comprised 36% (16 670) incisional hernias and 64% (29 006) primary hernias. Women had a higher risk for reoperation during index admission after primary hernia repair (OR 1.84 (1.29-2.62)). Forty-three patients died of complications within 30 days of index surgery. Patients aged 80 years and older had a 2.5 times higher risk for a complication leading to reoperation, and a 12-fold higher mortality risk than patients aged 70-79 years. Age is the dominant mortality risk factor in ventral hernia repair. Laparoscopic surgery was associated with a lower risk for reoperation during index admission. Reoperation seems to be a valid outcome variable, while registration of complications is generally poor in this type of cohort.

Sections du résumé

BACKGROUND AND AIMS OBJECTIVE
Ventral hernia repair is one of the most common surgical procedures performed worldwide. Despite the large volume, consensus is lacking regarding indications for repair or choice of surgical method used for reconstruction. The aim of this study was to explore the risk for major complications and mortality in ventral hernia repair using data from a nationwide patient register.
METHOD METHODS
Patient data of individuals over 18 years of age who had a ventral hernia procedure between 2004 and 2014 were retrieved from the Patient Register kept by the Swedish National Board of Health and Welfare. After exclusion of patients with concomitant bowel surgery, 45 676 primary surgical admissions were included. Procedures were dichotomised into laparoscopic and open surgery, and stratified for primary and incisional hernias.
RESULTS RESULTS
A total of 45 676 admissions were analysed. The material comprised 36% (16 670) incisional hernias and 64% (29 006) primary hernias. Women had a higher risk for reoperation during index admission after primary hernia repair (OR 1.84 (1.29-2.62)). Forty-three patients died of complications within 30 days of index surgery. Patients aged 80 years and older had a 2.5 times higher risk for a complication leading to reoperation, and a 12-fold higher mortality risk than patients aged 70-79 years.
CONCLUSION CONCLUSIONS
Age is the dominant mortality risk factor in ventral hernia repair. Laparoscopic surgery was associated with a lower risk for reoperation during index admission. Reoperation seems to be a valid outcome variable, while registration of complications is generally poor in this type of cohort.

Identifiants

pubmed: 36514042
doi: 10.1186/s12893-022-01873-9
pii: 10.1186/s12893-022-01873-9
pmc: PMC9749316
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

426

Informations de copyright

© 2022. The Author(s).

Références

Ann Surg. 2012 Jan;255(1):176-80
pubmed: 21677561
Hernia. 2018 Dec;22(6):947-950
pubmed: 30386922
Arch Surg. 2010 Aug;145(8):739-44
pubmed: 20713925
Int J Surg. 2015 Aug;20:65-74
pubmed: 26074289
Scand J Surg. 2019 Mar;108(1):30-35
pubmed: 29966500
Hernia. 2012 Apr;16(2):179-83
pubmed: 21904861
N Engl J Med. 2000 Aug 10;343(6):392-8
pubmed: 10933738
Ann Surg. 2017 Jan;265(1):80-89
pubmed: 28009730
Hernia. 2021 Apr;25(2):463-469
pubmed: 33230648
World J Surg. 2018 Nov;42(11):3528-3536
pubmed: 29700567
Dan Med J. 2016 Jul;63(7):
pubmed: 27399983
Hernia. 2015 Jun;19(3):449-63
pubmed: 25650284
Am Surg. 2016 Apr;82(4):E93-5
pubmed: 27097616
Surgery. 2020 Mar;167(3):614-619
pubmed: 31883632
World J Surg. 2019 Apr;43(4):988-997
pubmed: 30483884
Br J Surg. 2003 Apr;90(4):454-9
pubmed: 12673748
BJS Open. 2021 Mar 5;5(2):
pubmed: 33839749
Am J Surg. 2016 Sep;212(3):501-10
pubmed: 27443426
Surg Clin North Am. 2018 Jun;98(3):431-440
pubmed: 29754613
Ann Surg. 2012 Dec;256(6):955-8
pubmed: 22580941
World J Surg. 2013 Oct;37(10):2273-9
pubmed: 23756775
BJS Open. 2017 Nov 09;1(5):128-137
pubmed: 29951615
JAMA. 2016 Oct 18;316(15):1575-1582
pubmed: 27750295
Scand J Surg. 2015 Jun;104(2):66-71
pubmed: 24820660
Hernia. 2021 Aug;25(4):951-956
pubmed: 34297251
Hernia. 2019 Dec;23(6):1081-1091
pubmed: 31754953
Hernia. 2013 Aug;17(4):487-92
pubmed: 23793858
Int J Surg. 2018 Mar;51:114-119
pubmed: 29413874
Ann Surg. 2013 Jul;258(1):37-45
pubmed: 23629524
BMC Public Health. 2011 Jun 09;11:450
pubmed: 21658213
Plast Reconstr Surg. 2018 Sep;142(3 Suppl):21S-29S
pubmed: 30138261
Ann Surg. 2003 Jan;237(1):129-35
pubmed: 12496540
Hernia. 2019 Oct;23(5):831-845
pubmed: 31549324
JAMA Surg. 2018 Feb 1;153(2):160-168
pubmed: 29049457

Auteurs

Mikael Lindmark (M)

Department of Surgical and Perioperative Sciences, Umeå University, Umeå, Sweden. mikael.e.lindmark@umu.se.

Thyra Löwenmark (T)

Department of Surgical and Perioperative Sciences, Umeå University, Umeå, Sweden.

Karin Strigård (K)

Department of Surgical and Perioperative Sciences, Umeå University, Umeå, Sweden.

Ulf Gunnarsson (U)

Department of Surgical and Perioperative Sciences, Umeå University, Umeå, Sweden.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH